Jan Bell Email & Phone Number

Thousand Oaks, CA, US

• Promote IV immunotherapy oncologic BITE technology antibody construct Blincyto (Acute Lymphoblastic Leukemia).
• Call on Adult/Pediatric Hematologists and BMT Specialists in major academic centers, regional hospitals and Dept. of Defense institutions and develop productive KOL relationships.
• Partner with stakeholders in the malignant rare disease space across the MD, NJ, DE, DC, and VA region.
• Employ a relationship based and consultative sales approach to understand provider approach and clinical needs.
• Implement effective marketing strategies to successfully position product in disease landscape.
• Key Accomplishments:- Gained product adoption at Johns Hopkins, UMMC, UVA, MedStar/GU/, Hackensack/JSUMC, INOVA, Walter Reed, UVA Health, Virginia Cancer Specialists, Children’s National Hospital, Christiana Hospital.

Thousand Oaks, CA, US

• Neulasta/Onpro device (leukocyte growth factor), Vectibix (EGFR - metastatic colorectal cancer) Imlygic (genetically modified oncolytic viral therapy -melanoma), Xgeva (bone mets), Nplate (immune thrombocytopenia).
• Called on Oncologists/Hematologists across the Washington DC, Maryland, and Virginia region.
• Employed a relationship-based and consultative sales approach in hospitals and cancer centers.
• Created opportunities within the territory proactively to maintain and grow product market share.
• Planned and executed the territory businesses plans to focus on the pull-through of brand messaging.
• Identified and fostered relationships with Key Opinion Leaders and planned and executed speaker programs.

Boston, MA, US

• Represented Merck Oncology portfolio. Managed sales and marketing for an oncology portfolio including Intron A, Sylatron, Temodar, Emend.
• Called on Oncologists in academic centers and cancer centers across the Chicago region.
• Initiated and facilitated medical education program on Treatment Strategies for CINV at Rush University.
• Partnered with Northwestern Memorial Melanoma KOLs and pharmacy managers to gain formulary approval.
• Utilized a combination of market analysis, strategic planning, and advanced selling skills to drive sales growth.
• Key Accomplishments:- Influenced key decision makers to positively impact the Rush System EMR anti-emetogenic protocols.- Achieved formulary win for Sylatron and gained melanoma protocol inclusion at Northwestern.

Foster City, CA, US

• Promoted Ranexa (anti-ischemic/anti-anginal therapy) across four states in the Midwest region.
• Called on Cardiologists in hospitals and Cardiology Clinics.
• Focused on building trusted and respected relationships with providers and office staff through consultative selling.
• Key Accomplishment: Increased product access with reimbursement resources.

Indianapolis, Indiana, US

• Marketed a portfolio of IV products including Reopro (monoclonal antibody initiated in cardiac cath lab), Xigris (biologic-Severe Sepsis/Septic Shock), Humulin (insulin), and Effient (P2Y12 platelet inhibitor) in.
• Called on Interventional Cardiology, Pulm/Critical Care, Hem/Onc, Infectious Disease, Trauma, and Emergency dept.
• Key Accomplishments:- Ranked in the Top 10% nationally for Reopro Market Share growth with 122% in 2010 and159% in 2011- Achieved major product conversion at Northwestern Memorial Hospital for Humulin.- Recognized with.

Master Of Business Administration - Mba, Health/Health Care Administration/Management

Bachelor Of Arts - Ba, Business Administration And Management, General

Fashion Merchandising/Marketing Management